171 related articles for article (PubMed ID: 24354058)
1. [Vaccines against highly pathogenic influenza viruses of the avian origin].
Sergeeva MV; Romanova IuR
Vopr Virusol; 2013; 58(4):4-9. PubMed ID: 24354058
[TBL] [Abstract][Full Text] [Related]
2. Development of live attenuated influenza vaccines against pandemic influenza strains.
Coelingh KL; Luke CJ; Jin H; Talaat KR
Expert Rev Vaccines; 2014 Jul; 13(7):855-71. PubMed ID: 24867587
[TBL] [Abstract][Full Text] [Related]
3. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2012 Oct; 87(42):401-12. PubMed ID: 23113329
[No Abstract] [Full Text] [Related]
4. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2012 Mar; 87(11):97-108. PubMed ID: 22462204
[No Abstract] [Full Text] [Related]
5. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2014 Mar; 89(11):105-15. PubMed ID: 24707515
[No Abstract] [Full Text] [Related]
6. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2013 Oct; 88(42):449-63. PubMed ID: 24159668
[No Abstract] [Full Text] [Related]
7. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2013 Mar; 88(11):117-25. PubMed ID: 23544238
[No Abstract] [Full Text] [Related]
8. Development of vaccine strains of H5 and H7 influenza viruses.
Soda K; Sakoda Y; Isoda N; Kajihara M; Haraguchi Y; Shibuya H; Yoshida H; Sasaki T; Sakamoto R; Saijo K; Hagiwara J; Kida H
Jpn J Vet Res; 2008 Jan; 55(2-3):93-8. PubMed ID: 18318111
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses.
Hassan AO; Amen O; Sayedahmed EE; Vemula SV; Amoah S; York I; Gangappa S; Sambhara S; Mittal SK
PLoS One; 2017; 12(10):e0186244. PubMed ID: 29023601
[TBL] [Abstract][Full Text] [Related]
10. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
[TBL] [Abstract][Full Text] [Related]
11. The development of vaccine viruses against pandemic A(H1N1) influenza.
Robertson JS; Nicolson C; Harvey R; Johnson R; Major D; Guilfoyle K; Roseby S; Newman R; Collin R; Wallis C; Engelhardt OG; Wood JM; Le J; Manojkumar R; Pokorny BA; Silverman J; Devis R; Bucher D; Verity E; Agius C; Camuglia S; Ong C; Rockman S; Curtis A; Schoofs P; Zoueva O; Xie H; Li X; Lin Z; Ye Z; Chen LM; O'Neill E; Balish A; Lipatov AS; Guo Z; Isakova I; Davis CT; Rivailler P; Gustin KM; Belser JA; Maines TR; Tumpey TM; Xu X; Katz JM; Klimov A; Cox NJ; Donis RO
Vaccine; 2011 Feb; 29(9):1836-43. PubMed ID: 21199698
[TBL] [Abstract][Full Text] [Related]
12. Vaccines to protect humans from pandemic avian influenza strains.
Campbell JD
Md Med; 2006; 7(1):15-8. PubMed ID: 16613361
[TBL] [Abstract][Full Text] [Related]
13. Influenza: lessons from past pandemics, warnings from current incidents.
Horimoto T; Kawaoka Y
Nat Rev Microbiol; 2005 Aug; 3(8):591-600. PubMed ID: 16064053
[TBL] [Abstract][Full Text] [Related]
14. Universal influenza vaccines: a realistic option?
de Vries RD; Altenburg AF; Rimmelzwaan GF
Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S120-S124. PubMed ID: 27130671
[TBL] [Abstract][Full Text] [Related]
15. Vaccines for pandemic influenza.
Luke CJ; Subbarao K
Emerg Infect Dis; 2006 Jan; 12(1):66-72. PubMed ID: 16494720
[TBL] [Abstract][Full Text] [Related]
16. Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms.
Luke CJ; Subbarao K
Expert Rev Vaccines; 2014 Jul; 13(7):873-83. PubMed ID: 24855993
[TBL] [Abstract][Full Text] [Related]
17. Emerging influenza viruses and the prospect of a universal influenza virus vaccine.
Krammer F
Biotechnol J; 2015 May; 10(5):690-701. PubMed ID: 25728134
[TBL] [Abstract][Full Text] [Related]
18. Immunocapture isotope dilution mass spectrometry in response to a pandemic influenza threat.
Pierce CL; Williams TL; Santana WI; Levine M; Chen LM; Cooper HC; Solano MI; Woolfitt AR; Marasco WA; Fang H; Donis RO; Barr JR
Vaccine; 2017 Sep; 35(37):5011-5018. PubMed ID: 28774565
[TBL] [Abstract][Full Text] [Related]
19. Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.
Isakova-Sivak I; Rudenko L
Expert Rev Vaccines; 2015; 14(10):1313-29. PubMed ID: 26289975
[TBL] [Abstract][Full Text] [Related]
20. Universal influenza vaccines, science fiction or soon reality?
de Vries RD; Altenburg AF; Rimmelzwaan GF
Expert Rev Vaccines; 2015; 14(10):1299-301. PubMed ID: 26104835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
